Data as of Mar 14
| -0.36 / -2.66%|
The 5 analysts offering 12-month price forecasts for Derma Sciences Inc have a median target of 19.00, with a high estimate of 22.00 and a low estimate of 16.00. The median estimate represents a +44.16% increase from the last price of 13.18.
The current consensus among 6 polled investment analysts is to Buy stock in Derma Sciences Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.